Today, 28 April 2022 Icon Group and Varian (a Siemens Healthineers company) announced a five-year research and professional services agreement. Through this agreement, Icon will participate in clinical and technical research programs, product evaluation projects, and clinical consultations with Varian to offer clinical expertise and industry perspectives throughout product development.
The strategic partnership enables business leaders across Varian, Siemens Healthineers, and Icon to collaborate on new learnings and techniques in radiation therapy to advance patient-centric solutions and accelerate the development of market-ready products.
Icon Group CEO, Mark Middleton said, “We are proud to have a long-standing global relationship with Varian who share the same mission and patient-centric approach to cancer care. Through this five-year partnership, we look forward to once again supporting Varian’s world-class team in developing products and services that have the potential to efficiently deliver more advanced care to even more patients in more regions across the world.”
